These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 8395493

  • 21. In vitro assessment of the postantibiotic effect of lomefloxacin against gram-positive and gram-negative pathogens.
    Debbia EA, Pesce A, Schito GC.
    Am J Med; 1992 Apr 06; 92(4A):45S-47S. PubMed ID: 1316070
    [Abstract] [Full Text] [Related]

  • 22. Comparative in-vitro activity of fleroxacin against 480 nosocomial isolates.
    Sofianou D, Frantzidou F, Tsakris A.
    J Chemother; 1994 Dec 06; 6(6):399-403. PubMed ID: 7699427
    [Abstract] [Full Text] [Related]

  • 23. Cross-resistance and cross-susceptibility between fluoroquinolone agents.
    Barry AL, Fuchs PC.
    Eur J Clin Microbiol Infect Dis; 1991 Dec 06; 10(12):1013-8. PubMed ID: 1666360
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Comparison of in vitro antimicrobial activity of AM-1155 with those of tosufloxacin and fleroxacin against clinical isolates of Neisseria gonorrhoeae harboring quinolone resistance alterations in GyrA and ParC.
    Deguchi T, Yasuda M, Nakano M, Ozeki S, Kanematsu E, Fukuda H, Maeda S, Saito I, Kawada Y.
    Chemotherapy; 1997 Dec 06; 43(4):239-44. PubMed ID: 9209780
    [Abstract] [Full Text] [Related]

  • 26. Impermeability to quinolones in gram-positive and gram-negative bacteria.
    Bryan LE, Bedard J.
    Eur J Clin Microbiol Infect Dis; 1991 Apr 06; 10(4):232-9. PubMed ID: 1864283
    [Abstract] [Full Text] [Related]

  • 27. Antibacterial activity of lomefloxacin.
    Leigh DA, Tait S, Walsh B.
    J Antimicrob Chemother; 1991 May 06; 27(5):589-98. PubMed ID: 1885417
    [Abstract] [Full Text] [Related]

  • 28. Phenotypic characterization of quinolone-resistant mutants of Enterobacteriaceae selected from wild type, gyrA type and multiply-resistant (marA) type strains.
    Piddock LJ, Hall MC, Walters RN.
    J Antimicrob Chemother; 1991 Aug 06; 28(2):185-98. PubMed ID: 1663926
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Mechanisms of quinolone resistance in clinical isolates: accumulation of sparfloxacin and of fluoroquinolones of various hydrophobicity, and analysis of membrane composition.
    Denis A, Moreau NJ.
    J Antimicrob Chemother; 1993 Sep 06; 32(3):379-92. PubMed ID: 8262860
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Antimicrobial susceptibility testing of newer quinolones against gram positive and gram negative clinical isolates.
    Iffat W, Shoaib MH, Muhammad IN, Rehana, Tasleem S, Gauhar S.
    Pak J Pharm Sci; 2010 Jul 06; 23(3):245-9. PubMed ID: 20566434
    [Abstract] [Full Text] [Related]

  • 33. Comparative in-vitro activity of Ro 23-6240, a new trifluorinated quinolone.
    Verbist L.
    J Antimicrob Chemother; 1987 Sep 06; 20(3):363-72. PubMed ID: 3119552
    [Abstract] [Full Text] [Related]

  • 34. In vitro activities of five quinolones against Chlamydia pneumoniae.
    Hammerschlag MR, Hyman CL, Roblin PM.
    Antimicrob Agents Chemother; 1992 Mar 06; 36(3):682-3. PubMed ID: 1320366
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The in-vitro activity of two new quinolones: rufloxacin and MF 961.
    Wise R, Andrews JM, Matthews R, Wolstenholme M.
    J Antimicrob Chemother; 1992 Jun 06; 29(6):649-60. PubMed ID: 1324239
    [Abstract] [Full Text] [Related]

  • 37. In-vitro comparison of DU-6859a, a novel fluoroquinolone, with other quinolones and oral cephalosporins tested against 5086 recent clinical isolates.
    Marshall SA, Jones RN, Murray PR, Washington JA, Allen SD, Gerlach EH, Erwin ME.
    J Antimicrob Chemother; 1993 Dec 06; 32(6):877-84. PubMed ID: 8144428
    [No Abstract] [Full Text] [Related]

  • 38. [The serum bactericidal activity of domestic fleroxacin and lomefloxacin].
    Zhao M, Jiang S, Wang R.
    Zhonghua Nei Ke Za Zhi; 1999 Feb 06; 38(2):98-100. PubMed ID: 11798634
    [Abstract] [Full Text] [Related]

  • 39. In vitro activity of the active metabolite of prulifloxacin (AF 3013) compared with six other fluoroquinolones.
    Prats G, Roig C, Miró E, Navarro F, Mirelis B.
    Eur J Clin Microbiol Infect Dis; 2002 Apr 06; 21(4):328-34. PubMed ID: 12072950
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.